cascades induced by cross-talk between angiotensin II and aldosterone. J Mol Med. 2008V86N6
7
Atlas SA；. The Renin-Angiotensin Aldosterone
System:Pathophysiological Role and Pharmacologic Inhibition. J Manag Care Pharm. 2007V13N8SB:9-20
8
Mackins CJ；Kano S；Seyedi N；Schafer U；Reid AC；Machida T；Silver RB；Levi R；Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest. 2006V116N4：1063-1070 9
Huang BS；Leenen FH；The brain renin-angiotensin-aldosterone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction. Curr Heart Fail Rep. 2009V6N2：81-88 10
Gao L；Wang WZ；Wang W；Zucker IH；Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure. Hypertension. 2008V52N4：708-714 11
Gao L；Wang W；Li YL；Schultz HD；Liu D；Cornish KG；Zucker IH；Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol. 2005V288N5：H2271-H2279 12
Engelhardt S; Hein L; Dyachenkow V; Kranias EG; Isenberg G; Lohse MJ; Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation. Circulation. 2004V109N9:1154-1160 13
van der Velden J；Merkus D；Klarenbeek BR；James AT；Boontje NM；Dekkers DH；Stienen GJ；Lamers JM；Duncker DJ；Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction. Circ Res. 2004V95N11. e85-e95 14
Yoshikawa T； Role of sympathoadrenal activations in
congestive heart failure. Nippon Rinsho. 2006V64N5：832-836 15
Miskin R；Abramovitz R；Enhancement of PAI-1 mRNA in
cardiovascular cells after kainate injection is mediated through the sympathetic nervous system. J Mol Cell Cardiol. 2005V38N5：715-722
16
Tamum N，Ogawa Y，Chusho H，et a1．Cardiac fibrosis in mice
lacking brain natriuretic
peptide[J]．Prec Nail Acad Sci USA，2000，97(8)：4239--4244．
17
Yoshizumi M，Tsuji H，Nishimura H，et a1．Natriuretic pepfides
reS~ ,e the expression
of tissue factor and PAl一1 in endothehal ceils[J]．Thromb Hacmcst，1999，82：1497—1503．
18
Jourdain P；Jondeau G；Funck F；Gueffet P；Le Helloco A；Donal E；Aupetit JF；Aumont MC；Galinier M；Eicher JC；Cohen Solal A；Juilliere Y；Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol. 2007V49N16：1733-1739 19
Porter KE; Turner NA; Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009V123N2:255-278 20
Schorlemmer A；Matter ML；Shohet RV；Cardioprotective signaling by endothelin. Trends Cardiovasc Med. 2008V18N7：233-239. 21
Zykov KA；Tatenkulova SN；Masenko VP；Kuznetsova TV；Rvacheva AV；Belenkov IuN；Characteristics of autoimmune reactions in chronic cardiac failure of different etiology. Ter Arkh. 2009V81N4：22-28 22
Rosello Lleti E；Rivera M；Bertomeu V；Cortes R；Jordan A；Gonzalez Molina A；Interleukin-4 and cardiac fibrosis in patients with heart failure. Rev Esp Cardiol. 2007V60N7：777-780 23
Horio T；Pathophysiological role of cytokines in heart failure. Nippon Rinsho. 2006V64N5：843-847 24
Wang Y；Zhou Y；Meng L；Lu X；Ou N；Li X；Inflammatory mediators in Chinese patients with congestive heart failure. J Clin Pharmacol. 2009V49N5：591-599
25
Porter KE；Turner NA；Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009V123N2：255-278. 26
Stewart JA Jr, Massey EP, Fix C, Zhu J, Goldsmith EC, Carver W. Temporal alterations in cardiac fibroblast function following induction of pressure overload. Cell Tissue Res. 2010 Mar 9. [Epub ahead of print]. 27
Nishida K, Otsu K. Cell death in heart failure. Circ J. 2008;72 Suppl A:A17-21. 28
Chandrashekhar Y；Role of apoptosis in ventricular remodeling. Curr Heart Fail Rep. 2005V2N1.18-22 29
Wu F；Zhang J；Beard DA；Experimentally observed phenomena on cardiac energetics in heart failure emerge from simulations of cardiac metabolism. Proc Natl Acad Sci U S A. 2009V106N17:7143-7148 30
Joanne S. Ingwall. Energy metabolism in heart failure and remodeling. Cardiovasc Res. 2009 February 15; 81(3): 412–419. 31
Wallis J；Lygate CA；Fischer A；ten Hove M；Schneider JE；Sebag Montefiore L；Dawson D；Hulbert K；Zhang W；Zhang MH；Watkins H；Clarke K；Neubauer S；Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine
transporter-overexpressing transgenic mice. Circulation. 2005V112N20.3131-3139.
32
Maral Ouzounian, Douglas S Lee and Peter P Liu. Diastolic
heart failure: mechanisms and controversies. Nat Clin Pract Cardiovasc Med. 2008V5N7:375-386
33
Westermann D；Kasner M；Steendijk P；Spillmann F；Riad A；Weitmann K；Hoffmann W；Poller W；Pauschinger M；Schultheiss HP；Tschope C；Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation. 2008V117N16：2051-2060
34
Attila Borbély, Zoltán Papp, István édes, Walter J. Paulus；
Molecular determinants of heart failure with normal left
ventricular ejection fraction. Pharmacological Reports.2009, 61, 139–145
35
Maral Ouzounian, Douglas S Lee and Peter P Liu. Diastolic heart failure: mechanisms and controversies. Nat Clin Pract Cardiovasc Med. 2008V5N7:375-386 36
Paradis P；Dali Youcef N；Paradis FW；Thibault G；Nemer M；Overexpression of angiotensin II type I receptor in
cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci U S A. 2000V97N2. 931-936 37
Horio T；Pathophysiological role of cytokines in heart failure. Nippon Rinsho. 2006V64N5：843-847. 38
Sun M；Chen M；Dawood F；Zurawska U；Li JY；Parker T；Kassiri Z；Kirshenbaum LA；Arnold M；Khokha R；Liu PP；Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation. 2007V115N11. 1398-1407. 39
Kockskamper J；Zima AV；Roderick HL；Pieske B；Blatter LA；Bootman MD；Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes. J Mol Cell Cardiol. 2008V45N2. 128-147. 40
Dent MR；Dhalla NS；Tappia PS；Phospholipase C gene expression, protein content, and activities in cardiac hypertrophy and heart failure due to volume overload. Am J Physiol Heart Circ Physiol. 2004V287N2.H719-H727 41
Onohara N；Nishida M；Inoue R；Kobayashi H；Sumimoto H；Sato Y；Mori Y；Nagao T；Kurose H；TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J. 2006V25N22. 5305-5316 42
Haendeler J；Berk BC；Angiotensin II mediated signal
transduction. Important role of tyrosine kinases. Regul Pept. 2000V95N1-3. 1-7. 43
Lamba S；Abraham WT；Alterations in adrenergic receptor signaling in heart failure. Heart Fail Rev. 2000V5N1. 7-16 44
van der Velden J；Merkus D；Klarenbeek BR；James AT；Boontje NM；Dekkers DH；Stienen GJ；Lamers JM；Duncker DJ；Alterations in myofilament function contribute to left ventricular
dysfunction in pigs early after myocardial infarction. Circ Res. 2004V95N11. e85-e95 45
Fu YC；Yin SC；Chi CS；Hwang B；Hsu SL；Norepinephrine induces apoptosis in neonatal rat endothelial cells via a ROS-dependent JNK activation pathway. Apoptosis. 2006V11N11：2053-2063. 46
Qin F；Shite J；Liang CS；Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways. Am J Physiol Heart Circ Physiol. 2003V285N2. H822-H832. 47
Schiekofer S；Shiojima I；Sato K；Galasso G；Oshima Y；Walsh K；Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. Physiol Genomics. 2006V27N2. 156-170 48
Boengler K；Hilfiker Kleiner D；Drexler H；Heusch G；Schulz R；The myocardial JAK/STAT pathway: from protection to failure. 172-185. 49
Kao YH；Chen YC；Cheng CC；Lee TI；Chen YJ；Chen SA；Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes. Crit Care Med. 2010V38N1. 217-222. 50
Bovill E；Westaby S；Reji S；Sayeed R；Crisp A；Shaw T；Induction by left ventricular overload and left ventricular failure of the human Jumonji gene (JARID2) encoding a protein that
regulates transcription and reexpression of a protective fetal program. J Thorac Cardiovasc Surg. 2008V136N3. 709-716 51
Lin Z；Murtaza I；Wang K；Jiao J；Gao J；Li PF；miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci U S A. 2009V106N29. 12103-12108 52
Misquitta CM；Iyer VR；Werstiuk ES；Grover AK；The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology. Mol Cell Biochem. 2001V224N1-2. 53-67.